上海实业控股有限公司
menu
Home
About Us
Our Businesses
Corporate Governance
Investor Relations
Corporate News
search
email
-
+
disclaimer
sitemap
print
EN
繁
簡
Home
Search
Search result for ""
search
October
Disposed 43.62% shareholding of SI Pharmaceutical and all interests in other SIHL pharmaceutical companies, realizing total proceeds of HK$5,750 million and a disposal gain of about HK$3,000 million.
Aug/Dec
Acquisition from parent company of four land lots located in Shanghai's Qingpu District, right beside Dianshan Lake, for HK$3,109 million.
July
Disposed entire shareholding of 8.2% in SMIC, realizing divestment proceeds of HK$1,100 million, and a disposal loss of HK$715 million.
June/July
Disposed entire shareholding of 35.176% in Bright Dairy for HK$2,152 million, logging a post-tax disposal gain of HK$1,078 million.
June
Acquisition of 4 residential blocks of Shanghai Bay for HK$2,227 million, with total guaranteed profit return of approximately HK$1,022 million in three years.
June
Disposed 18.89% equity interest in MicroPort Medical for HK$516 million, recording a disposal gain of HK$383 million.
January
Disposed 21.17% equity interest in Lianhua Supermarket for RMB1,056 million, recording a post-tax disposal gain of HK$125 million.
October
Disposed 30% interest in Zhejiang Yongjin Expressway at a consideration of RMB 360 million.
September
Resolutions of proposed acquisition of Shanghai Four Seasons Hotel and Hu-Hang Expressway (Shanghai section) interests was approved at the Extraordinary General Meeting.
July
Proposed acquisition of 87% interests of Shanghai Four Seasons Hotel and 100% interests of Hu-Hang Expressway (Shanghai section) from parent company for a consideration of about HK$5.546 billion.
May
Disposed 20% interest in Shanghai Information Investment, with HK$775 million divestment proceeds.
June
Acquired 40% equity interest of Shanghai Urban Development (Holdings) Co., Ltd. ("SUDH") for a consideration of about RMB 2,131 million, establishing real estate as one of SIHL's core ...
August
Divested from logistics-related businesses to optimize SIHL's infrastructure business portfolio, realizing a cash income of RMB205 million.
September
Selected as a Hang Seng Index Constituent Stock.
May
Proposed to transfer 5 Chinese medicine assets to SI Pharmaceutical at a total consideration of RMB1,515 million (subsequently discontinued due to regulatory approvals not being obtained).
November
Signed a HK$3 billion syndicated loan.
April
Disposed 10% interest in Waigaoqiao Container Port Phase 1, realizing a cash income of RMB465 million.
December
New drugs "Oncorine", "Kai Li Kang" and "TNF" received State Category One New Drug Certificates by the State Food and Drug Administration.
October
Disposed 28.15% stake in Shanghai Jahwa, realizing a cash income of RMB337 million.
June
Increased General Water of China's registered capital to RMB1 billion.
if($PageTotal > 1 && $_REQUEST['all'] == ''){ ?>
<<
<
...
6
7
8
9
10
...
Next >
>>
}else if( $_REQUEST['all'] != ''){ ?>
View 20 per page
}else{ ?>
} ?>